Advertisement
UK markets close in 6 minutes
  • FTSE 100

    8,124.49
    -42.27 (-0.52%)
     
  • FTSE 250

    20,200.50
    -21.58 (-0.11%)
     
  • AIM

    764.06
    -1.12 (-0.15%)
     
  • GBP/EUR

    1.1808
    +0.0034 (+0.29%)
     
  • GBP/USD

    1.2680
    +0.0030 (+0.24%)
     
  • Bitcoin GBP

    48,879.29
    -674.67 (-1.36%)
     
  • CMC Crypto 200

    1,310.27
    -34.23 (-2.55%)
     
  • S&P 500

    5,481.46
    +6.37 (+0.12%)
     
  • DOW

    39,173.32
    +3.80 (+0.01%)
     
  • CRUDE OIL

    83.36
    -0.02 (-0.02%)
     
  • GOLD FUTURES

    2,338.10
    -0.80 (-0.03%)
     
  • NIKKEI 225

    40,074.69
    +443.63 (+1.12%)
     
  • HANG SENG

    17,769.14
    +50.53 (+0.29%)
     
  • DAX

    18,159.46
    -131.20 (-0.72%)
     
  • CAC 40

    7,540.38
    -20.75 (-0.27%)
     

Possible Bearish Signals With IDEXX Laboratories Insiders Disposing Stock

Many IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, if numerous insiders are selling, shareholders should investigate more.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

Check out our latest analysis for IDEXX Laboratories

IDEXX Laboratories Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the insider, James Polewaczyk, for US$3.1m worth of shares, at about US$511 per share. So what is clear is that an insider saw fit to sell at around the current price of US$487. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

ADVERTISEMENT

IDEXX Laboratories insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume

I will like IDEXX Laboratories better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Insiders At IDEXX Laboratories Have Sold Stock Recently

The last three months saw significant insider selling at IDEXX Laboratories. In total, Independent Director Bruce Claflin dumped US$108k worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. IDEXX Laboratories insiders own 0.9% of the company, currently worth about US$380m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The IDEXX Laboratories Insider Transactions Indicate?

An insider hasn't bought IDEXX Laboratories stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. But since IDEXX Laboratories is profitable and growing, we're not too worried by this. It is good to see high insider ownership, but the insider selling leaves us cautious. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

But note: IDEXX Laboratories may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com